Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2005-12-15 Director's Dealing
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2005-12-15 English
PRIMARY DOCUMENT
Director's Dealing
2005-12-15 English
PRIMARY DOCUMENT
Director's Dealing
2005-12-15 English
PRIMARY DOCUMENT
Director's Dealing
2005-12-15 English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-4
Transaction in Own Shares Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to Form S-4 filed with the SEC by Johnson & Johnson. Form S-4 is a registration statement used for securities issued in connection with mergers and acquisitions. The text discusses the merger agreement, shareholder meeting notices, proxy statements, and details about the merger consideration. It includes information about the special meeting of shareholders to approve the merger and proxy solicitation materials. The document is not a financial report, earnings release, or audit report, but rather a regulatory filing related to a merger transaction and securities registration. Therefore, the most appropriate classification is 'POS' (Transaction in Own Shares), as it relates to the registration and issuance of shares in connection with the merger transaction.
2005-12-06 English
PRIMARY DOCUMENT
Director's Dealing
2005-11-21 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.